Some patients find that remaining at a lower maintenance dose, whilst potentially sacrificing some glycaemic or weight loss benefits, provides an acceptable balance between efficacy and tolerability
Pioglitazone, which also stimulates PPAR (e.g
Abrupt discontinuation isn't dangerous with GLP-1 drugs, but a gap of more than 12 weeks may reset your tolerance, meaning you'd likely restart at a lower dose if resuming after a break
It focuses on how food intake, strength training, hydration, and recovery are described in established medical and scientific sources
Faraji Rad Z, Prewett PD, Davies GJ
Compounded semaglutide is not covered by insurance because it is not approved by the FDA